Suchergebnisse - "SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2"

PubPharm (485)

11

Inhibition of SARS-CoV-2 nucleocapsid protein-RNA interaction by guanosine oligomeric RNA

enthalten in: Journal of biochemistry | 2023

von Sekine, R. | Tsuno, S. | Irokawa, H. | +6

12

A Global, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Adults Aged 18 Years and Older : A Global, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Adults Aged 18 Years and Older

enthalten in: WHO International Clinical Trials Registry Platform | 2023

13

A Partially-Blinded, Randomized, Phase 3 Study to Evaluate the Immunogenicity and Safety of CpG/Alum-adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine (SCB-2019) in Healthy Adults and Individuals with HIV Infection : Phase 3 Study of Immunogenicity and Safety of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine in Healthy Adults and Individuals with HIV Infection

enthalten in: WHO International Clinical Trials Registry Platform | 2023

14

A Phase III Clinical Trial of Influenza Virus Vector Covid-19 Vaccine for Intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1) : A Global, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy and Safety of Influenza Virus Vector Covid-19 Vaccine for Intranasal spray (DelNS1-2019-nCoV-RBD-OPT1) in Adults Aged 18 Years and Older.

enthalten in: WHO International Clinical Trials Registry Platform | 2023

15

Robust specific RBD responses and neutralizing antibodies after ChAdOx1 nCoV-19 and CoronaVac vaccination in SARS-CoV-2- seropositive individuals

enthalten in: The journal of allergy and clinical immunology. Global | 2023

von Fernandes, E. | Taminato, M. | de Souza Apostolico, J. | +6

16

Safety and tolerability of Evusheld in patients with CVID : The Mayo Clinic experience

enthalten in: The journal of allergy and clinical immunology. Global | 2023

von Squire, J. | Pitlick, M. | Freeman, C. | +1

17

Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score

enthalten in: Mayo Clinic proceedings. Innovations, quality & outcomes | 2023

von Johnson, P. | Kunze, K. | Senefeld, J. | +29

18

SARS-CoV-2 concentration in wastewater consistently predicts trends in COVID-19 case counts by at least two days across multiple WWTP scales

enthalten in: Environmental advances | 2023

von Swift, C. | Isanovic, M. | Correa Velez, K. | +1

19

Jeopardies in human security and politicization of COVID-19

enthalten in: Ethics, medicine, and public health | 2023

von Pachankis, Y.

20

Fluorophore-encapsulated nanobeads for on-site, rapid, and sensitive lateral flow assay

enthalten in: Sensors and actuators. B, Chemical | 2023

von Seo, S. | Ryu, E. | Kim, J. | +2